Cargando…
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
With increasing knowledge of clinical in vivo biomarkers and the pathological intricacies of Alzheimer's disease (AD), nosology is evolving. Harmonized consensus criteria that emphasize prototypic illness continue to develop to achieve diagnostic clarity for treatment decisions and clinical tri...
Autores principales: | Lam, Benjamin, Masellis, Mario, Freedman, Morris, Stuss, Donald T, Black, Sandra E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580331/ https://www.ncbi.nlm.nih.gov/pubmed/23302773 http://dx.doi.org/10.1186/alzrt155 |
Ejemplares similares
-
Clinical dementia severity associated with ventricular size is differentially moderated by cognitive reserve in men and women
por: Sapkota, Shraddha, et al.
Publicado: (2018) -
Effects of white matter hyperintensities, neuropsychiatric symptoms, and cognition on activities of daily living: Differences between Alzheimer's disease and dementia with Lewy bodies
por: Mirza, Saira Saeed, et al.
Publicado: (2022) -
White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer’s disease
por: Desmarais, Philippe, et al.
Publicado: (2021) -
Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story
por: Lam, Benjamin, et al.
Publicado: (2009) -
APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia
por: Mirza, Saira Saeed, et al.
Publicado: (2019)